The effect of intravenous infusion of isoproterenol on myocardial oxygen consumption ( Vo 2 ) was studied in 10 intact and anesthetized dogs before and after inhibition of lipolysis. In five dogs lipolysis was inhibited by nicotinic acid or beta pyridyl carbinol and in five other dogs by high plasma glucose concentrations. In spite of similar mechanical responses to isoproterenol, as evidenced by left ventricular pressure, maximal rate of rise of left ventricular pressure (dP/dt), heart rate and cardiac output, augmentation of Vo 2 was larger before (on average 7.6 ml/min·100 g) than after inhibition of lipolysis either by antilipolytic drugs (on average 4.5 ml/min·100 g) (P < 0.005), or by high plasma glucose concentrations (on average 4.3 ml/min·100 g) (P < 0.02). As mechanical responses to isoproterenol were similar before and after inhibition of lipolysis, it is concluded that the additional rise in Vo 2 with intact lipolysis was caused by a metabolic stimulation by high concentrations of free fatty acids.
INTRODUCTION
Stimulation of P-adrenergic receptors, e.g. by isoproterenol, increases the mechanical performance of the heart and has a marked effect on myocardial oxygen consumption (MVo2).' The augmented MVo2 has previously been related to increased mechanical activity of the heart (1, 2) . In an earlier study it was found that increased myocardial uptake of free fatty acids (FFA) was accompanied by raised myocardial oxygen consumpReceived for publication 16 February 1971 Intravenous infusion of isoproterenol began 15 min later. The infusion rate was adjusted so as to reach the same dP/dt as in the control run. This led to comparable changes in all hemodynamic parameters measured. The dose of isoproterenol needed was similar to that used in the control run. In about 10 min, stable conditions were reached, and registrations and blood samples were obtained.
Group II also consisted of five dogs. Registrations and blood sampling were performed before and after 10 min constant i.v. infusion of isoproterenol at a rate of 2-3 ,ug/ min. 30 min after discontinuing isoproterenol infusion, lipolysis was inhibited by plasma glucose concentrations of about 250 mg/100 ml. Plasma glucose was raised by i.v.
injection of 40-50 ml 10-20%o glucose solution followed by infusion at a constant rate of 1 ml/min. Control samples were obtained 30 min later; i.v. infusion of isoproterenol was started at a similar infusion rate as in the control run.
Stable conditions were reached after 10 min infusion of isoproterenol, and new blood samples were obtained for metabolic studies.
Control studies with two repetitive i.v. infusions of isoproterenol at similar rates, without inhibition of lipolysis, showed a similar rise in mechanical performance, M'7o2, arterial concentration, and myocardial uptake of FFA in both experimental settings.
Calculations. Left ventricular work (LVW) (kg-m/minkg) was calculated as 0.0136 X CO X LVSP (15) , where CO is cardiac output (ml/min-kg), and LVSP (left ventricular systolic pressure) (mm Hg). MVo2 (ml/min-100 g) was calculated from the oxygen extraction of the myocardium and MF. Myocardial uptake of FFA (.uEq/min 100 g) was calculated as the product of arteriocoronary sinus differences of FFA and myocardial plasma flow.
To evaluate differences, probability values were obtained utilizing Student's t test for paired data.
RESULTS
Group I. Hemodynamic data before and during i.v. infusion of isoproterenol, without and with inhibition of lipolysis by nicotinic acid or beta pyridyl carbinol, are presented in Table I . The isoproterenol-induced changes in mechanical activity, as evidenced by AP, LVSP, left ventricular end-diastolic pressure (LVEDP), dP/dt, heart rate (HR), CO, and LVW, were similar before and after inhibition of lipolysis. Table II shows metabolic data before and after inhibition of lipolysis. While isoproterenol infusion raised plasma FFA and myocardial uptake of FFA two-to threefold in control experiments, these increases were abolished by nicotinic acid or beta pyridyl carbinol. Infusion of isoproterenol raised MVo2 in all experiments. However, the augmentation was larger (P < 0.005) before (on average 7.7 ml/min 100 g) than after (on average 4.5 ml/min. 100 g) inhibition of lipolysis. MF increased similarly with isoproterenol before (on average 63 ml/min-100 g) and after (on average 68 ml/min-100 g) inhibition of lipolysis. The higher MVo2 during isoproterenol infusion in control experiments was due to larger (P < 0.01) myocardial oxygen extraction, as opposed to increased coronary flow, than with inhibited lipolysis.
Group II. The isoproterenol-induced changes in mechanical activity, as evidenced by AP, LVSP, LVEDP, dP/dt, HR, CO, and LVW, were similar before -and after inhibition of lipolysis by high plasma glucose concentrations (Table III) . Table IV shows metabolic data before and after inhibition of lipolysis. In control experiments, i.v. infusion of isoproterenol raised plasma FFA three-to fourfold and myocardial uptake of FFA 5-6 times. At high plasma glucose concentrations, the increments in plasma FFA and myocardial uptake of FFA were less than in control experiments, averaging only, 56 and 21%, respectively, of the increments seen in the control experiments. Isoproterenol infusion raised MVo2 in all experiments. However, the augmentation of MVo2 was larger (P < 0.02) before (on average 7.5 ml/min-100 g) than after (on average 4.3 ml/min 100 g) inhibition of lipolysis. MF increased similarly in control experiments (on average 57 ml/min 100 g) and by inhibition of lipolysis (on average 50 ml/min. 100 g). Higher MVo2 For abbreviations, see Table I .
Free Fatty Acids and Myocardial Oxygen Consumption during isoproterenol infusion before than after high plasma glucose concentrations was primarily due to larger (P < 0.02) myocardial oxygen extraction.
DISCUSSION
Catecholamine-induced changes in MVo2 in beating hearts have usually been attributed to inotropic and chronotropic stimulation of the mechanical activity of the heart (1, 2). However, the isoproterenol-induced rise in MVo2 was significantly reduced after inhibition of lipolysis, despite similar effects on mechanical activity of the heart, as evidenced by LVSP, LVEDP, dP/dt, HR, and LVW. The present study therefore supports the concept that the calorigenic action of catecholamines in the beating heart is partly attributable to their FFA-mobilizing action as shown in the isolated heart (16, 17) . A similarly reduced isoproterenol-induced rise in MNTo2 with antilipolytic drugs or high plasma glucose concentrations indicates that this effect was not confined to the agents per se. The common cause was probably a largely abolished rise in myocardial uptake of FFA by isoproterenol in both groups, suggesting a causal relationship between myocardial uptake of FFA and oxygen consumption. In the presence of nicotinic acid or beta pyridyl carbinol, this can be solely explained by the abolished rise in plasma FFA as a consequence of complete inhibition of lipolysis in adipose tissue. However, as the isoproterenol-induced rise in plasma FFA was reduced by an average of only 44% in the glucose series, an additional suppressive effect of high glucose concentrations on myocardial uptake of FFA must be postulated in order to explain our findings.
The present data indicate that the larger rise in MVo2 by isoproterenol before than after inhibition of lipolysis is related to the high myocardial uptake of circulatory FFA. However, previous in vitro studies have suggested increased endogenous lipolysis within the heart by catecholamines (16, 17) . It is therefore conceivable that increased myocardial lipolysis would contribute to the rise in MVo2 in addition to the effect of circulatory FFA. Thus MVo2 would be expected to increase more for a given rise in myocardial uptake of FFA during isoproterenol infusion than for a similar exogenously induced rise in myocardial uptake of FFA. In accordance with this interpretation, the present study shows an almost doubled rise in MVoN for a similar increase in myocardial uptake of FFA with isoproterenol compared with that induced by i.v. infusion of Intralipid (Vitrium, Stockholm, Sweden) in heparinized dogs (3) .
The higher MVo2 with isoproterenol alone was principally due to larger myocardial oxygen extraction than after inhibition of lipolysis. If Po2 were the only determinant of MF, it would be expected that with isoproterenol alone MF would be larger than after inhibition of lipolysis. However, as proposed by Berne (18) , metabolites like adenosine probably play an important role in the regulation of MF. The present experiments appear to suggest that regulation of MF, and probably also the production of adenosine, is not completely dependent on myocardial metabolism, but seems to be better related to mechanical activity. (27) , this treatment has been directed rather towards replacing intracellular potassium than depressing myocardial uptake of FFA through high plasma glucose concentrations. As a result, plasma FFA and myocardial uptake of FFA were not measured in these studies.
The exact mechanism for the metabolic stimulation of high concentrations of FFA is not known. It may be due to an uncoupling action of high intracellular concentrations of FFA on oxidative phosphorylation (16, 17, 28) .
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